About Norstella
At Norstella, our mission is simple: to help our clients bring life-saving therapies to market quicker—and help patients in need. Founded in 2022, but with history going back to 1939, Norstella unites best-in-class brands to help clients navigate the complexities at each step of the drug development life cycle—and get the right treatments to the right patients at the right time.

Each organization (Citeline, Evaluate, MMIT, Panalgo, The Dedham Group) delivers must-have answers for critical strategic and commercial decision-making. Together, via our market-leading brands, we help our clients:

• Citeline – accelerate the drug development cycle
• Evaluate – bring the right drugs to market
• MMIT – identify barriers to patient access
• Panalgo – turn data into insight faster
• The Dedham Group – think strategically for specialty therapeutics

By combining the efforts of each organization under Norstella, we can offer ...